Skip to main content
All lobbying firms

TIBER CREEK HEALTH STRATEGIES, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$3,560,000 Income reported
12 Clients represented
65 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (400712135), not by name.

 Lobbyists named 1
  • DAN ZAWITOSKI 1 filing · through 2025 Chief of Staff, Rep. Scott Peters (2018-2023); Legislative Director, Rep. Scott Peters (2015-2018); Legislative Assistant, Rep. Scott Peters (2014-2015); Legis…

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $1,040,000 20 filings
  • 2025 $2,520,000 45 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • SENATE 17
  • HOUSE OF REPRESENTATIVES 12
 Recent filings 65 total
Q2Y
TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)
2nd Quarter (Apr 1 - June 30) 2026 · $50,000 income · posted Jul 19, 2026
View →
Q2Y
ELI LILLY AND COMPANY
2nd Quarter (Apr 1 - June 30) 2026 · $80,000 income · posted Jul 19, 2026
View →
Q2Y
TIBER CREEK GROUP (ON BEHALF OF EMD SERONO, INC.)
2nd Quarter (Apr 1 - June 30) 2026 · $50,000 income · posted Jul 19, 2026
View →
Q2Y
TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC)
2nd Quarter (Apr 1 - June 30) 2026 · $50,000 income · posted Jul 19, 2026
View →
Q2Y
GENENTECH, INC.
2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 19, 2026
View →
Q2Y
TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)
2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 18, 2026
View →
Q2
GRAIL, LLC
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 18, 2026
View →
Q2
FRESENIUS MEDICAL CARE NORTH AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 18, 2026
View →
Q2Y
NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 17, 2026
View →
Q1
GRAIL, LLC
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q1
FRESENIUS MEDICAL CARE NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q1Y
NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 20, 2026
View →
1TY
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 20, 2026
View →
Q1Y
TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)
1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 19, 2026
View →
Q1Y
TIBER CREEK GROUP (ON BEHALF OF EMD SERONO, INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · $50,000 income · posted Apr 19, 2026
View →
Q1Y
TIBER CREEK GROUP (ON BEHALF OF MERCK & CO INC)
1st Quarter (Jan 1 - Mar 31) 2026 · $50,000 income · posted Apr 19, 2026
View →
Q1Y
TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)
1st Quarter (Jan 1 - Mar 31) 2026 · $50,000 income · posted Apr 18, 2026
View →
Q1Y
ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · $80,000 income · posted Apr 18, 2026
View →
Q1Y
GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 18, 2026
View →
1TY
AMGEN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 10, 2026
View →

Showing the 20 most recent of 65 filings. Search the explorer for "TIBER CREEK HEALTH STRATEGIES, INC.".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem